Abstract:Objective To investigate the safety and efficacy of organ preservation surgery or "watch and wait" strategy for rectal cancer patients who are evaluated as clinical complete response (cCR) or near-cCR following neoadjuvant chemoradiotherapy (nCRT).Method From March 2011 to June 2016,35 patients with mid-low rectal cancers who were diagnosed as cCR or near-cCR following nCRT underwent organ preservation surgery with local excision or surveillance following "watch and wait" strategy in the Peking University Cancer Hospital.All the patients received re-evaluation and re-staging 6-12 weeks after the completion of nCRT,according to Habr-Gama and MSKCC criteria for the diagnosis of cCR or near-cCR.The near-cCR patients who received local excision and were pathologically diagnosed as T0Nx were also regarded as cCR.The end-points of this study included organ-preservation rate (OPR),sphincter-preservation rate (SPR),non-re-growth disease-free survival (NR-DFS),stoma-free survival,cancer-specific survival (CSS) and overall survival (OS).Kaplan-Meier curve was used to estimate the survival data at 3 years.Results A total of 35 cases were analyzed including 24 males (68.6％) and 11 females (31.4％).The median age was 60 (range 37-79) years and the median distance from tumor to anal edge was 4 (2-8) cm.Thirty-three patients received 50.6 Gy/22f IMRT with capecitabine and two patients received 50 Gy/25f RT with capecitabine.The cCR and near-cCR rates were 74.3％(26/35) and 25.7％ (9/35) respectively.Excision biopsy was performed in 4 near-cCR cases to confirm the diagnosis of cCR.The non-re-growth DFS rate was 14.3％(5/35) and the median time of tumor re-growth was 6.7 (4.7-37.4) months.In five patients with tumor re-growth,four were salvaged by radical rectal resections and one received local excision.The distant metastasis rate was 5.7％ (2/35),one patient presented resectable liver metastasis and received radical resection,another patient presented multiple bone metastases and was still alive.The median follow-up time was 43.7 (6.1-71.4) months.At three years,the organ-preservation rate was 88.6％ (31/35),the sphincter-preservation rate was 97.1％ (34/35).No local recurrence was observed in five patients who received salvage surgery.The non-re-growth DFS was 94.0％.Three patients died of non-rectal cancer related events.The cancer-specific survival was 100％,the overall survival was 92.7％ and the stoma-free survival rate was 90.0％.Conclusions Organ preservation surgery or "watch and wait" strategy for cCR or near-cCR patients is feasible and achieves good outcomes.This strategy can be an alternative to standard care,improve patient's quality of life and facilitate tailored treatment for mid-low rectal cancer following nCRT,however,it should be cautiously applied in near-cCR patients before local excision biopsy.

Effectiveness of Organ Preservation for Locally Advanced Rectal Cancer With Complete Clinical Response After Neoadjuvant Chemoradiotherapy: Bayesian Network Meta-analysis

Neoadjuvant Radiotherapy Improves Overall Survival for T3/4N+M0 Rectal Cancer Patients: a Population-Based Study of 20300 Patients

Efficacy and safety of neoadjuvant chemoradiotherapy versus neoadjuvant radiotherapy for stages II-III rectal cancer: a Meta-analysis

Outcome of watch and wait strategy or organ preservation for rectal cancer following neoadjuvant chemoradiotherapy: report of 35 cases from a single cancer center

Effect of Interval Between Neoadjuvant Chemoradiotherapy and Surgery on Oncological Outcomes in Poor Responders with Locally Advanced Rectal Cancer: a Retrospective Cohort Study.

Treatment Options for Distal Rectal Cancer in the Era of Organ Preservation

Optimal Timing of Surgery for Locally Advance Rectal Cancer: How We Choose

Predictors and Risk Factors of Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer: A Population-Based Analysis

Changing Patterns of Neoadjuvant Therapy for Locally Advanced Rectal Cancer: A Narrative Review

Long-term prognostic analysis on complete / near-complete clinical remission for mid-low rectal cancer after neoadjuvant chemoradiotherapy

Overall Survival Benefit in Rectal Cancer After Neoadjuvant Radiotherapy and Adjuvant Chemotherapy: A Propensity-Matched Population-Based Study

Efficacy and Safety of Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: a Meta-Analysis

[Efficacy of neoadjuvant radiochemotherapy in treatment of locally advanced low rectal cancer]

Survival analysis in patients with pathological complete response of locally advanced rectal cancer after neoadjuvant chemoradiotherapy

Effect of preoperative radiochemotherapy on the treatment of low rectal cancer

Research Progress of Neoadjuvant Therapy for Locally Advanced Rectal Cancer

Effects of neoadjuvant chemotherapy with or without intensity‐modulated radiotherapy for patients with rectal cancer

Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Metaanalysis of Oncological and Operative Outcomes

Neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced rectal cancer: A new era for anal preservation

[Advances of Optimized Neoadjuvant Therapy in the Treatment of Locally Advanced Rectal Cancer].

Advances in Preoperative Radiation of Locally Advanced Rectal Cancer